Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05420662
Other study ID # KAEK /05.bI.05
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 14, 2022
Est. completion date December 27, 2023

Study information

Verified date December 2023
Source Kocaeli University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

If a vaginal manipulator is used for abdominal hysterectomy, the vagina can be cut and separated from the cervix without cutting the Cardinal and Sacrouterine ligaments and protecting the top of the vaginal tissue (Portio vaginalis). In this way, both the shortening of the vagina and the prolapse of the vaginal cuff can be prevented. In addition, the duration of hysterectomy surgery is significantly shortened.


Description:

In a classical abdominal hysterectomy, the Cardinal ligaments and the Sacrouterine ligaments are cut before the uterus leaves the vagina, and the vaginal cuff is cut deeper in the vagina over the cervix and separated from the vagina. During this procedure, the vaginal tissue in the Portio vaginalis comes out and causes a loss of vaginal length. If a vaginal manipulator is used for abdominal hysterectomy, the vagina can be cut and separated from the cervix without cutting the Cardinal and Sacrouterine ligaments and protecting the top of the vaginal tissue (Portio vaginalis). In this way, both the shortening of the vagina and the prolapse of the vaginal cuff can be prevented. In addition, the duration of hysterectomy surgery is significantly shortened.


Recruitment information / eligibility

Status Completed
Enrollment 132
Est. completion date December 27, 2023
Est. primary completion date December 26, 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Women who underwent hysterectomy due to abnormal uterine bleeding - Myoma uteri, little than 5 cm which does not disrupt the uterine anatomy Exclusion Criteria: - Myoma uteri, which disrupts the uterine anatomy - Intra-abdominal adhesions - Endometrial intraepithelial neoplasia - Endometrial cancer - Ovarian cancer - Cervical cancer

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Manipulation of vagina during abdominal hysterectomy operation
The manipulator applied vaginally prevents unnecessary vaginal length loss by ensuring that the vaginal cuff is cut from the top point.
Classical conventional abdominal hysterectomy operation
Classical conventional abdominal hysterectomy operation without any manipulation from the vagina.

Locations

Country Name City State
Turkey Kocaeli University Kocaeli

Sponsors (1)

Lead Sponsor Collaborator
Kocaeli University

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Kiyak H, Karacan T, Ozyurek ES, Turkgeldi LS, Kadirogullari P, Seckin KD. Abdominal Hysterectomy with a Uterine Manipulator Minimizes Vaginal Shortening: A Randomized Controlled Trial. J Invest Surg. 2021 Oct;34(10):1052-1058. doi: 10.1080/08941939.2020.1744774. Epub 2020 Apr 2. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Vaginal Length Difference The difference between preoperative and postoperative vaginal length will be calculated Preoperative one hour and postoperative one hour
Secondary Operation time Skin-to-skin operation time and the time frame from the beginning of the hysterectomy to the moment when the uterus leaves the vagina. One to two hours
See also
  Status Clinical Trial Phase
Recruiting NCT05644873 - Intravenous Administration of Magnesium Sulfate in Hysterectomy Cases N/A
Completed NCT03443271 - Effect of TAP Block on Stress Hormones Phase 4
Completed NCT01492075 - A Comparison Between Continuous and Intermittent Intraabdominal Analgesia Using Local Anaesthetics Phase 4
Completed NCT04366375 - Pentraxin-3 in Hysterectomy Patients
Completed NCT04724564 - Correlation of Different Time Measurements of the Surgical PLETH Index With Postoperative Pain
Completed NCT03748108 - Bolus Administration of Intravenous Lidocaine at the Time of Abdominal Hysterectomy N/A
Completed NCT03965637 - Intravenous Ascorbic Acid Administration in Hysterectomy Phase 3
Not yet recruiting NCT06367595 - Effect of Intrathecal Magnesium Sulfate Versus Intravenous Magnesium Sulfate on Postoperative Pain After Abdominal Hysterectomy Phase 2
Completed NCT05611944 - Irrigation and Suction Trial to Prevent SSI N/A